The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


Acacia species (Mimosaceae) are used in Sudanese traditional medicine to treat various inflammatory diseases. The present study was designed to investigate the effect of dichloromethane (DCM) and 90% methanol extracts of bark and leaves of three Acacia species on cycoloxygenase-1 (COX-1) and -2 (COX-2) enzymes. The investigated species were: A. nilotica subsp. tomentosa, A. nubica and A. senegal subsp. senegal. The results showed that DCM bark extracts of all species showed high COX-2 selective inhibition (IC50 values of 0.45, 37 and 17.3 μg/mL) compared to COX-1 inhibition (IC50 values of 206.3, >250, >250 μg/mL) respectively. The DCM bark extracts of the three species were evaluated further in vivo in rats with adjuvant-induced arthritis. DCM bark extracts of A. senegal significantly reduced the edema when administered at a dose of 300 mg/kg. The extract did not cause lesions in the gastrointestinal mucosa compared to indomethacin which caused severe lesions in the small intestine (ulcer index = 194.3±2.7 mm2). On the other hand, DCM bark extracts of A. nubica and A. nilotica were not active in in vivo assay. The results suggest that DCM bark extracts of A. senegal subsp. senegal may be useful in the treatment of rheumatoid arthritis.

Keywords

Acacia, Adjuvant Arthritis, Anti-inflammatory Activity, Cox-1, Cox-2, Mimosaceae
Font Size

User

Notifications
JOURNAL COVERS